TAG
Dr Ram Vishwakarma
A Covid pill likely to get approval within next few days
In a major development, Merck and Ridgeback’s investigational oral antiviral Molnupiravir for the treatment of mild-to-moderate Covid-19 is likely to get approval “within days.”
The...